DHG Pharmaceutical JSC Total Liabilities
DHG Pharmaceutical JSC total liabilities. Based on the latest financial reports, DHG Pharmaceutical JSC (DHG) has total liabilities worth ₫1.59 Trillion VND (≈ $60.29 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check asset resilience ratio of DHG Pharmaceutical JSC to evaluate the company's liquid asset resilience ratio.
Total Liabilities of DHG Pharmaceutical JSC (2019–2025)
Total liabilities of DHG Pharmaceutical JSC from 2019 to 2025. This chart illustrates how DHG Pharmaceutical JSC's total liabilities have evolved over time, based on quarterly financial data.
DHG Pharmaceutical JSC Competitors by Total Liabilities
The table below lists competitors of DHG Pharmaceutical JSC ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
First Tractor Company Limited
F:FTP
|
Germany | €6.87 Billion |
|
Enity
ST:ENITY
|
Sweden | Skr35.75 Billion |
|
NH SPAC 8
KQ:225570
|
Korea | ₩148.24 Billion |
|
Ackerstein Group Ltd
TA:ACKR
|
Israel | ILA637.23 Million |
|
Tokmanni Group Oyj
HE:TOKMAN
|
Finland | €1.19 Billion |
|
Shanthi Gears Limited
NSE:SHANTIGEAR
|
India | Rs1.16 Billion |
|
Solusi Bangun Indonesia Tbk PT
JK:SMCB
|
Indonesia | Rp7.25 Trillion |
|
ATN International Inc
NASDAQ:ATNI
|
USA | $1.16 Billion |
Liability Composition Analysis (2019–2025)
This chart breaks down DHG Pharmaceutical JSC's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see DHG asset base.
Liquidity & Leverage Metrics
DHG Pharmaceutical JSC Total Liabilities Ratios Explained
DHG Pharmaceutical JSC total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.47 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.46 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.32 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how DHG Pharmaceutical JSC's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for DHG Pharmaceutical JSC (2019–2025)
The table below shows the annual total liabilities of DHG Pharmaceutical JSC from 2019 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | ₫983.26 Billion ≈ $37.36 Million |
-47.26% |
| 2024-12-31 | ₫1.86 Trillion ≈ $70.84 Million |
+48.26% |
| 2023-12-31 | ₫1.26 Trillion ≈ $47.78 Million |
+43.45% |
| 2022-12-31 | ₫876.65 Billion ≈ $33.31 Million |
+6.32% |
| 2021-12-31 | ₫824.52 Billion ≈ $31.33 Million |
-6.25% |
| 2020-12-31 | ₫879.46 Billion ≈ $33.41 Million |
+14.32% |
| 2019-12-31 | ₫769.27 Billion ≈ $29.23 Million |
-- |
About DHG Pharmaceutical JSC
DHG Pharmaceutical Joint Stock Company, together with its subsidiaries, engages in the manufacture and sale of pharmaceutical products in Vietnam. The company offers antibiotic, analgesic and antipyretic, respiratory, nutrition, musculoskeletal, gastrointestinal and hepatobiliary, nervous and ophthalmic, cardiovascular and diabetic, dermatology, and beauty care products. It also manufactures and … Read more